Evidence map›Paper›PMID 40144410›Full record

ArticleCureus2025

Elevated D-dimer Levels in the Exacerbation of End-Stage Chronic Obstructive Pulmonary Disease (COPD) With Hypercapnia.

Brittany E Reid, Stephen DiGiuseppe, Hesam Akbarian-Tefaghi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brittany E ReidOsteopathic Medicine, Edward Via College of Osteopathic Medicine, Monroe, USA.
Stephen DiGiuseppeMicrobiology, Edward Via College of Osteopathic Medicine, Monroe, USA.
Hesam Akbarian-TefaghiHospital Medicine, Willis-Knighton Health System, Shreveport, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

D-dimer levels can be elevated in a variety of conditions including pulmonary embolism, deep vein thrombosis, disseminated intravascular coagulation, pregnancy, cigarette smoking, and infection. It has been proposed that D-dimer levels in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) can predict short-term and long-term survival. Here, we present a case of an elderly male who presented to the hospital with shortness of breath with an oxygen saturation of 77% on his two liters of home nasal cannula. He had a history of chronic obstructive pulmonary disease (COPD), heart failure with preserved ejection fraction (HFpEF), coronary artery disease, and current tobacco use. Labs indicated an elevated D-dimer level of 5.58 μg/mL. He was admitted to the intensive care unit (ICU) due to severe symptoms, which improved on bilevel positive airway pressure (BiPAP). His chest X-ray showed bilateral interstitial opacities with hyperexpansion. A computed tomography (CT) angiogram of the lungs did not show pulmonary embolism, but chronic bronchitis and severe emphysematous changes were evident. The patient's elevated D-dimer levels coincided with acute hypercapnic respiratory failure from end-stage (Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage IV) COPD. The patient's hospital course was complicated by pneumothorax on day 10 of admission. He was managed conservatively and transferred to long-term acute care due to the continued need for BiPAP support and a high-flow nasal cannula. This case and others continue to support that even very high levels of D-dimer in symptomatic patients may not indicate the presence of pulmonary embolism.

Indexed as

chronic obstructive pulmonary disease (copd)d-dimer levelselevated d-dimerhypercapniapulmonary disease

Identifiers

PMID40144410
PMCPMC11940554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.